Dimitri E. Grigoriadis, Chief Research Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 85,498 shares at $125.98 ($10.8M) on 2020-05-19, disclosed to the SEC on 2020-05-20.
Open-market sale of $10.8M NBIX by Chief Research Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $119.98 | 10,000 | $1.2M | 11.2% |
| 2 | $125.98 | 10,000 | $1.3M | 11.7% |
| 3 | $126.73 | 32,749 | $4.2M | 38.6% |
| 4 | $126.73 | 32,749 | $4.2M | 38.6% |
| Total | $125.85 avg | 85,498 | $10.8M | 100% |
| Filing → |
| NBIX | SELL | 2020-11-16 | $410K | — | Filing → |
| NBIX | SELL | 2020-08-07 | $536K | — | Filing → |
| NBIX | SELL | 2020-05-11 | $1.8M | — | Filing → |